Christopher Hergott, M.D., Ph.D. is a postdoctoral fellow at the Dana-Farber Cancer Institute (DFCI) and Associate Pathologist in hematopathology at Brigham and Women's Hospital (BWH) in Boston. He obtained his undergraduate degree in Biochemistry from the University of Rochester and his medical and graduate degrees from the University of Pennsylvania. He completed residency (and chief residency) in Clinical Pathology and a clinical fellowship in Hematopathology at BWH before beginning his postdoctoral research training in the laboratory of Dr. Benjamin Ebert at DFCI. Christopher's research interests lie at the intersection of inflammation and hematopoiesis, with a particular focus on clonal hematopoiesis and its progression to myeloid malignancies. In his free time, Christopher enjoys playing guitar, reading, and travelling.

Christopher Hergott MD, PhD
The Brigham and Women’s Hospital, Inc.
Boston, Massachusetts
United States
Project Title
Defining the role of IL-17A in propelling clonal cytopenia of undetermined significance
Program
Career Development Program